NDC Compounded Drug 70713-043-01 Testosterone; Anastrozole
Pellet, Implantable Subcutaneous
Compounded Drug Product Information
NDC Crossover Products Matching Testosterone; Anastrozole
NDC crossover of Testosterone Anastrozole Sa2 100mg 4mg with NDC 70713-043 a human compounded drug with other similar products matching the same substance name (Testosterone; Anastrozole) and the same administration route (subcutaneous) or dosage form (pellet, implantable).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
70713-014-01 | Testosterone Anastrozole Sa2 200mg 20mg | Testosterone Anastrozole Sa2 200mg 20mg | 1 PELLET, IMPLANTABLE in 1 BLISTER PACK | Pellet, Implantable | Subcutaneous | Wells Pharmacy, Inc |
70713-034-01 | Testosterone Anastrozole Sa2 200mg 8mg | Testosterone Anastrozole Sa2 200mg 8mg | 1 PELLET, IMPLANTABLE in 1 BLISTER PACK | Pellet, Implantable | Subcutaneous | Wells Pharmacy, Inc |
Frequently Asked Questions
What is the NDC number assigned to Testosterone Anastrozole Sa2 200mg 8mg?
Testosterone Anastrozole Sa2 200mg 8mg was assigned by its manufacturer with NDC product code 70713-043. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Testosterone Anastrozole Sa2 200mg 8mg?
The NDC package code 70713-043-01 was assigned to a 1 PELLET, IMPLANTABLE in 1 BLISTER PACK of testosterone; anastrozole administered subcutaneous via pellet, implantable.
Who manufactures this product?
Testosterone Anastrozole Sa2 200mg 8mg is manufactured by an outsourced facility and labeled by Wells Pharmacy, Inc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 2 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Wells Pharmacy, Inc with NDC product codes 70713-014-01 and 70713-034-01.